CA Stock MarketDetailed Quotes

HEM Hemostemix Inc

Watchlist
  • 0.080
  • 0.0000.00%
15min DelayPost Market Dec 23 15:05 ET
11.25MMarket Cap-2.58P/E (TTM)

About Hemostemix Inc Company

Hemostemix Inc is a biotechnology company. The company's principal business activity is developing, manufacturing, and commercializing blood-derived cell therapies for medical conditions. The Company's technology is a platform for developing autologous cell therapies to treat vascular diseases. The Company's clinical stage consists of ACP-01, autologous cell therapy for the treatment of critical limb ischemia.

Company Profile

SymbolHEM
Company NameHemostemix Inc
Founded2014
MarketTSX
Fiscal Year Ends12-31
Address707 - 7th Avenue SouthWest Suite 1150
CityCalgary
CountryCAN
Zip CodeT2P 3H6
Phone+1 905 580-4170

Company Executives

  • Name
  • Position
  • Salary
  • Thomas Smeenk
  • Director, President and Chief Executive Officer
  • --
  • Christina Wu
  • Interim Chief Financial Officer
  • --
  • Dr. Fraser C. Henderson
  • Chief Medical Officer
  • --
  • Peter Pavlin
  • Vice President of Operations
  • --
  • Peter Alan Lacey
  • Chairman of the Board
  • --
  • Loran Swanberg
  • Independent Director
  • --
  • Dr. Ronnie Hershman
  • Independent Director
  • --
Trending CA Stocks
Big Five Big Five

The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector. The "Big Five" refers to Canada's five largest banks—Royal Bank of Canada, Toronto-Dominion Bank, Bank of Nova Scotia, Bank of Montreal, and Canadian Imperial Bank of Commerce—which dominate and significantly influence the country's financial sector.